Clinical Trial Update: Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell [Phase 1]

View source ↗

Summary

Phase 1 study evaluating 111In-XYIMSR-01 for SPECT/CT imaging in patients with metastatic renal cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• 111In-XYIMSR-01 (Indium-111-labeled XYIMSR-01)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Renal Cell Carcinoma (Kidney Cancer) | Phase 1 | Status: RECRUITING